---
schema_version: "secwatch.filing_event.v1"
accession: "0001425450-23-000018"
form_type: "8-K"
ticker: "KIDS"
cik: "0001425450"
company_name: "ORTHOPEDIATRICS CORP"
filed_at: "2023-02-28T23:59:59+00:00"
generated_at: "2026-06-18T21:44:03.818593+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# OrthoPediatrics Q4 revenue up 25% to $31M; guides FY2023 revenue $146-149M

## Summary
- Q4 2022 revenue $31.0M (+25% YoY); FY2022 revenue $122.3M (+25% vs 2021).
- GAAP net loss in Q4 $7.8M ($0.35/share) vs net income $0.1M in Q4 2021; FY2022 net income $1.3M ($0.06/share).
- Adjusted EBITDA loss $2.2M in Q4 vs loss $0.6M a year ago; FY2022 adjusted EBITDA positive $0.2M.
- Trauma & Deformity segment Q4 revenue $22.1M (+34% YoY); Scoliosis $8.0M (+12%); Sports Med/Other $0.9M (-22%).
- International revenue grew 67% in Q4 and 47% for FY2022; cash $119.8M at Dec 31, 2022.

## SEC filing metadata
- accession: 0001425450-23-000018
- form_type: 8-K
- ticker: KIDS
- cik: 0001425450
- company_name: ORTHOPEDIATRICS CORP
- filed_at: 2023-02-28T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1425450/000142545023000018/0001425450-23-000018-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1425450/000142545023000018/kids-20230228.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001425450-23-000018
- JSON: https://secwatch.observer/filing/0001425450-23-000018.json
- Plain text: https://secwatch.observer/filing/0001425450-23-000018.txt

## Key facts
- Earnings Releases
  ORTHOPEDIATRICS CORP reported the fourth quarter and full year ended December 31, 2022 results: revenue $31.0 million. Guidance reaffirmed.
  - Period: the fourth quarter and full year ended December 31, 2022
  - Revenue: $31.0 million
  - Guidance: reaffirmed
  - Result: reported results
  source text: bringing the total to more than 630,000 since the inception of OrthoPediatrics when combined with MD Orthopaedics ("MD Ortho") and Pega Medical • Generated total revenue of $31.0 million for fourth quarter 2022, up 25% from $24.8 million in fourth quarter 2021; domestic revenue increased 15% and international revenue increased 67% in 2022 • Generated record total
  evidence_url: https://www.sec.gov/Archives/edgar/data/1425450/000142545023000018/0001425450-23-000018-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.